The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+10.7% to $28.20
Predicted High$28.20at 6 months
Predicted Low$25.10at 1 month
Max Drawdown (predicted)-1.5%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 13, 2026 1:03 am
Bull
CMCSA trends higher to
$28.20
(+10.7% from $25.47)
by Feb 2027.
dip-then-recover
ThesisCMCSA trades deeply below intrinsic value anchors but remains trapped by cable-decline sentiment and negative 6-month momentum. Value gravity slowly reasserts as the stock is already near the value-lens attractive zone, but the path is gradual with no earnings catalyst in-window. Modest drift higher, not a snap-back to fair value.
Invalidated ifA break below $23 on heavy volume or a subscriber/guide cut would invalidate; conversely a sustained move above $29 accelerates the thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $25.47 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 13, 2026
—
$25.47at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 27, 2026
$23.79–$27.15typical range · internal point $25.30
—
±6.6%
6/10
drift near current, weak sentiment offsets risk-on tape
1 month
Sep 13, 2026
$23.03–$27.91typical range · internal point $25.10
—
±9.6%
5/10
cable-narrative pressure lingers, no catalyst yet
2 months
Oct 13, 2026
$25.60
—
+0.5%
4/10
value buyers appear near attractive-below-30 zone
3 months
Nov 13, 2026
$26.40
—
+3.7%
5/10
Q3 print anticipation, beat-streak supports bid
4 months
Dec 13, 2026
$27.10
—
+6.4%
4/10
post-earnings drift if beat pattern holds
5 months
Jan 13, 2027
$27.60
—
+8.4%
4/10
value gravity slowly closes gap to anchors
6 months
Feb 13, 2027
$28.20
—
+10.7%
3/10
gradual mean-reversion toward prior target
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$47.88
(+88.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.